Organometallics p. 2049 - 2052 (2016)
Update date:2022-08-17
Topics:
Tondreau, Aaron M.
Boncella, James M.
(PNHP)Mn(CO)2 (I) carboxylate complexes (PNHP = HN{CH2CH2(PiPr2)}2) were prepared via 1,2-addition of either formic or oxalic acid to (PNP)Mn(CO)2 (PNP = the deprotonated, amide form of the ligand -N{CH2CH2(PiPr2)}2). The structural and spectral properties of these complexes were compared. The manganese formate complex was found to be dimeric in the solid state and monomeric in solution. Half an equivalent of oxalic acid was employed to form the bridging oxalate dimanganese complex. The catalytic competencies of the carboxylate complexes were assessed, and the formate complex was found to decompose formic acid catalytically. Both dehydrogenation and dehydration pathways were active as assessed by the presence of H2, CO2, and H2O. The addition of LiBF4 exhibited a strong inhibitory effect on the catalysis.
View MoreContact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
Contact:86-10-62983737; +86-10-51287608
Address:4/F Building C, 2 Shangdi Xinxi Road
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Qingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Doi:10.1002/chem.201000240
(2010)Doi:10.3390/61100900
(2001)Doi:10.1016/S0040-4020(03)00076-0
(2003)Doi:10.1021/acs.macromol.6b00714
(2016)Doi:10.1021/jp990664z
(1999)Doi:10.1016/0022-328X(87)80284-X
(1987)